Arbutus Biopharma
ABUS
#6394
Rank
A$0.98 B
Marketcap
$5.17
Share price
0.31%
Change (1 day)
48.43%
Change (1 year)

Arbutus Biopharma (ABUS) - Cash on Hand

Cash on Hand as of September 2024 : A$0.20 Billion

According to Arbutus Biopharma 's latest financial reports the company has A$0.20 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Arbutus Biopharma - Cash on Hand chart (from 2007 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31A$0.18 B-14.33%
2022-12-31A$0.21 B0.77%
2021-12-31A$0.21 B33.64%
2020-12-31A$0.16 B23.57%
2019-12-31A$0.12 B-26.66%
2018-12-31A$0.17 B9.3%
2017-12-31A$0.16 B-10.64%
2016-12-31A$0.18 B-27.22%
2015-12-31A$0.24 B81.6%
2014-12-31A$0.13 B77.9%
2013-12-31A$77.03 M70.25%
2012-12-31A$45.25 M415.8%
2011-12-31A$8.77 M-27.81%
2010-12-31A$12.15 M-53.15%
2009-12-31A$25.93 M-30.29%
2008-12-31A$37.2 M53.96%
2007-12-31A$24.16 M291.62%
2006-12-31A$6.17 M-56.92%
2005-12-31A$14.32 M-55.65%
2004-12-31A$32.29 M-38.77%
2003-12-31A$52.74 M-22.15%
2002-12-31A$67.75 M-27.3%
2001-12-31A$93.19 M117.35%
2000-12-31A$42.87 M43.65%
1999-12-31A$29.84 M183.03%
1998-12-31A$10.54 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$5.55 M-97.29%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.21 M-99.90% Bahamas